Accent Microcell

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Q5D01013
  • NSEID: ACCENTMIC
  • BSEID:
INR
460.10
-4.2 (-0.9%)
BSENSE

Jun 25, 10:22 AM

BSE+NSE Vol: 9000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 31.92% vs 7.77% in Mar 2025

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2026 is 32.67% vs 9.58% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 35.27% vs 6.16% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 54.29% vs -69.57% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Accent Microcell With
Markets Mojo
Figures in Cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
349.03
671.03
-322.00
-47.99%
Other Operating Income
0.00
0.00
0.00
Total Operating income
349.03
671.03
-322.00
-47.99%
Raw Material Cost
124.09
239.57
-115.48
-48.20%
Purchase of Finished goods
95.55
79.03
16.52
20.90%
(Increase) / Decrease In Stocks
-3.55
-7.44
3.89
52.28%
Employee Cost
18.21
125.19
-106.98
-85.45%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
58.05
137.00
-78.95
-57.63%
Total Expenditure (Excl Depreciation)
292.34
573.35
-281.01
-49.01%
Operating Profit (PBDIT) excl Other Income
56.69
97.68
-40.99
-41.96%
Other Income
6.77
33.45
-26.68
-79.76%
Operating Profit (PBDIT)
63.46
131.13
-67.67
-51.61%
Interest
0.54
1.01
-0.47
-46.53%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
62.92
130.12
-67.20
-51.64%
Depreciation
4.66
14.50
-9.84
-67.86%
Profit Before Tax
58.26
115.63
-57.37
-49.62%
Tax
14.40
27.73
-13.33
-48.07%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
43.86
87.89
-44.03
-50.10%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
43.86
87.89
-44.03
-50.10%
Equity Capital
23.99
20.03
3.96
19.77%
Face Value
10.00
10.00
0.00
Reserves
251.50
737.60
-486.10
-65.90%
Earnings per share (EPS)
18.28
43.88
-25.60
-58.34%
Diluted Earnings per share
18.65
43.88
-25.23
-57.50%
Operating Profit Margin (Excl OI)
16.24%
14.56%
0.00
1.68%
Gross Profit Margin
18.03%
19.39%
0.00
-1.36%
PAT Margin
12.57%
13.10%
0.00
-0.53%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 349.03 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 31.92% vs 7.77% in Mar 2025

Annual - Standalone Net Profit
Standalone Net Profit 43.86 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 32.67% vs 9.58% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 56.69 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 35.27% vs 6.16% in Mar 2025

Annual - Interest
Interest 0.54 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 54.29% vs -69.57% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.24%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has improved from Mar 2025